Hans Hull
CIK 1614876 · Chief Business Officer · last filed 2025-01-27
Hans Hull is a Chief Business Officer who has filed 26 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for PLRX, was dated Jan 27, 2025. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $288.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$288.7K
2
26
-$3.11M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLRX | Chief Business Officer | 255,529 | $1.13 | $288.7K | -$1.82M | 18 | 2025-01-27 |
| Adverum Biotechnologies, Inc. (AAVL) Delisted | Chief Executive Officer | 137,210 | — | — | -$1.29M | 8 | 2015-08-25 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-27 | PLRX | Grant (A) | +40,150 | $0 | EDGAR |
| 2025-01-22 | PLRX | Sell (S) | −15,936 | -$178.5K | EDGAR |
| 2024-07-12 | PLRX | Sell (S) | −9,900 | -$114.4K | EDGAR |
| 2024-07-11 | PLRX | Grant (A) | +19,337 | $0 | EDGAR |
| 2024-01-24 | PLRX | Grant (A) | +31,500 | $0 | EDGAR |
| 2024-01-19 | PLRX | Sell (S) | −9,786 | -$168.6K | EDGAR |
| 2023-08-07 | PLRX | Mixed | −20,728 | -$604.6K | EDGAR |
| 2023-07-19 | PLRX | Sell (S) | −17,937 | -$323.0K | EDGAR |
| 2023-07-18 | PLRX | Grant (A) | +35,156 | $0 | EDGAR |
| 2023-04-03 | PLRX | Sell (S) | −9,036 | -$239.6K | EDGAR |